Stigma of opioid addiction barrier to improving care

INCREASED COMPETITION: Dr. Jason Spangler, foreground, executive director of medical policy and quality strategies for Amgen, speaks during the Oct. 5 PBN Health Care Summit about how Amgen is working to lower prescription drug costs by increasing competition. / PBN PHOTO/RUPERT WHITELEY
INCREASED COMPETITION: Dr. Jason Spangler, foreground, executive director of medical policy and quality strategies for Amgen, speaks during the Oct. 5 PBN Health Care Summit about how Amgen is working to lower prescription drug costs by increasing competition. / PBN PHOTO/RUPERT WHITELEY

The stigma surrounding the opioid addiction is similar to that of the AIDS epidemic in recent decades, says Dr. Martin Serota, chief medical officer for Prospect Charter­Care Health Partners. The AIDS crisis became much more manageable with the cooperation of doctors, researchers and the pharmaceutical industry, he said. “We need to do the same thing

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber

No posts to display